BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30578463)

  • 1. Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts.
    Métayer LE; Brown RD; Carlebur S; Burke GAA; Brown GC
    Apoptosis; 2019 Feb; 24(1-2):145-156. PubMed ID: 30578463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of L-asparaginase in childhood ALL.
    Müller HJ; Boos J
    Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells.
    Mazloum-Ravasan S; Madadi E; Fathi Z; Mohammadi A; Mosafer J; Mansoori B; Mokhtarzadeh A; Baradaran B; Darvishi F
    Int J Biol Macromol; 2020 Mar; 146():193-201. PubMed ID: 31870867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.
    Avramis VI; Panosyan EH
    Clin Pharmacokinet; 2005; 44(4):367-93. PubMed ID: 15828851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.
    Mehta RK; Verma S; Pati R; Sengupta M; Khatua B; Jena RK; Sethy S; Kar SK; Mandal C; Roehm KH; Sonawane A
    J Biol Chem; 2014 Feb; 289(6):3555-70. PubMed ID: 24297177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
    Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
    Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
    Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
    Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
    Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
    Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
    Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
    Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in L-asparaginase discovery and its potential as anticancer agent.
    Shrivastava A; Khan AA; Khurshid M; Kalam MA; Jain SK; Singhal PK
    Crit Rev Oncol Hematol; 2016 Apr; 100():1-10. PubMed ID: 25630663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase.
    Hlozkova K; Pecinova A; Alquezar-Artieda N; Pajuelo-Reguera D; Simcikova M; Hovorkova L; Rejlova K; Zaliova M; Mracek T; Kolenova A; Stary J; Trka J; Starkova J
    BMC Cancer; 2020 Jun; 20(1):526. PubMed ID: 32503472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
    Wells JW; Evans CH; Scott MC; Rütgen BC; O'Brien TD; Modiano JF; Cvetkovic G; Tepic S
    PLoS One; 2013; 8(1):e54464. PubMed ID: 23365669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemia.
    Cory JG; Cory AH
    In Vivo; 2006; 20(5):587-9. PubMed ID: 17091764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
    Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
    J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL).
    Johnson S; Dhamne C; Sankaran H; Gandhi KA; Rane P; Moulik NR; Jadhav SM; Gurjar M; Narula G; Banavali S; Gota V
    Cancer Chemother Pharmacol; 2022 Dec; 90(6):445-453. PubMed ID: 36251032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-asparaginase: a promising chemotherapeutic agent.
    Verma N; Kumar K; Kaur G; Anand S
    Crit Rev Biotechnol; 2007; 27(1):45-62. PubMed ID: 17364689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia.
    Estlin EJ; Ronghe M; Burke GA; Yule SM
    Br J Haematol; 2000 Sep; 110(4):780-90. PubMed ID: 11054059
    [No Abstract]   [Full Text] [Related]  

  • 19. A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.
    Maggi M; Mittelman SD; Parmentier JH; Colombo G; Meli M; Whitmire JM; Merrell DS; Whitelegge J; Scotti C
    Sci Rep; 2017 Nov; 7(1):14479. PubMed ID: 29101342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-asparaginase.
    Fu CH; Sakamoto KM
    Expert Opin Pharmacother; 2007 Aug; 8(12):1977-84. PubMed ID: 17696798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.